Clinical Trial Detail

NCT ID NCT01553188
Title AMG 386 and Abiraterone for Advanced Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate cancer

Therapies

Prednisone

Abiraterone

Trebananib

Age Groups: adult

No variant requirements are available.